Not Yet RecruitingNot Applicable

Female Osteoporosis

1,500 participantsStarted 2026-02-04

Plain-language summary

The aim of this study is to compare the Osteoporosis Risk Assessment Tool and the Osteoporosis Self-Assessment Tool with the gold standard DEXA in determining the risk of osteoporosis in the lumbar and femoral regions in female individuals in the Turkish population, and to investigate their sensitivity and specificity in the first stage of screening for the detection of female osteoporosis.

Who can participate

Age range50 Years – 75 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Postmenopausal women aged 50-75 * Patients who underwent imaging with the STRATOS DEXA device at Kayseri City Hospital Exclusion criteria: * Patients younger than 50 or older than 75 years of age * Patients with secondary osteoporosis * Male patients * Patients with uncontrolled severe comorbid conditions * Patients with a history of pathological fractures

What they're measuring

Dual-energy X-ray absorptiometry (DEXA)

Timeframe: January 2021 - January 2024

Osteoporosis Self-Assessment Tool (OST)

Timeframe: January 2021 - January 2024

Osteoporosis Risk Assessment Index (ORAI)

Timeframe: January 2021 - January 2024

Trial details

NCT IDNCT07402772

SponsorKayseri City Hospital

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2026-02-04

Contact for this trial

Fatma Gül Ülkü Demir, MD

+903523157700 mdfgudemir@gmail.com

View on ClinicalTrials.gov More Female Osteoporosis trials